Cargando…

Role of obesity in a randomized placebo-controlled trial of difluoromethylornithine (DFMO) + sulindac for the prevention of sporadic colorectal adenomas

BACKGROUND: Chemoprevention with the polyamine-inhibitory regimen difluoromethylornithine (DFMO) + sulindac markedly reduces risk of recurrent adenoma in colorectal adenoma patients. Obesity is associated with risk of colorectal adenoma and colorectal cancer. This study investigates how obesity infl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zell, Jason A., Lin, Bruce S., Madson, Nikki, McLaren, Christine E., Gerner, Eugene W., Meyskens, Frank L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2012
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443348/ https://www.ncbi.nlm.nih.gov/pubmed/22907422 http://dx.doi.org/10.1007/s10552-012-0051-6

Ejemplares similares

Role of dietary polyamines in a phase III clinical trial of difluoromethylornithine (DFMO) and sulindac for prevention of sporadic colorectal adenomas
por: Raj, K P, et al.
Publicado: (2013)

Difluoromethylornithine (DFMO) and Neuroblastoma: A Review
por: Tangella, Adarsh Vardhan, et al.
Publicado: (2023)

Difluoromethylornithine (DFMO) and AMXT 1501 inhibit capsule biosynthesis in pneumococci
por: Ayoola, Moses B., et al.
Publicado: (2022)

Difluoromethylornithine (DFMO) Enhances the Cytotoxicity of PARP Inhibition in Ovarian Cancer Cells
por: El Naggar, Olivia, et al.
Publicado: (2022)

Chemoprevention of Colon Cancer by DFMO, Sulindac, and NO-Sulindac Administered Individually or in Combinations in F344 Rats
por: Madka, Venkateshwar, et al.
Publicado: (2023)

Thymoquinone and Difluoromethylornithine (DFMO) Synergistically Induce Apoptosis of Human Acute T Lymphoblastic Leukemia Jurkat Cells Through the Modulation of Epigenetic Pathways
por: Alhosin, Mahmoud, et al.
Publicado: (2020)

Difluoromethylornithine (DFMO), an Inhibitor of Polyamine Biosynthesis, and Antioxidant N-Acetylcysteine Potentiate Immune Response in Mice to the Recombinant Hepatitis C Virus NS5B Protein
por: Lesnova, Ekaterina I., et al.
Publicado: (2021)

Differential preventive activity of sulindac and atorvastatin in Apc(+/Min-FCCC)mice with or without colorectal adenomas
por: Chang, Wen-Chi L, et al.
Publicado: (2018)

Mutational Analysis of ZFY in Sporadic Parathyroid Adenomas
por: Romano, Robert, et al.
Publicado: (2017)

A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma
por: Saulnier Sholler, Giselle L., et al.
Publicado: (2015)

Maintenance DFMO Increases Survival in High Risk Neuroblastoma
por: Sholler, Giselle L. Saulnier, et al.
Publicado: (2018)

Sulindac plus a phospholipid is effective for polyp reduction and safer than sulindac alone in a mouse model of colorectal cancer development
por: Davis, Jennifer S., et al.
Publicado: (2020)

Therapy of murine squamous cell carcinomas with 2-difluoromethylornithine
por: Chen, Yan, et al.
Publicado: (2004)

Sulindac targets nuclear β-catenin accumulation and Wnt signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell lines
por: Boon, E M J, et al.
Publicado: (2004)

Chromosome 5 allele loss in familial and sporadic colorectal adenomas.
por: Rees, M., et al.
Publicado: (1989)

Deletion analysis of chromosome 8p in sporadic colorectal adenomas.
por: Cunningham, C., et al.
Publicado: (1994)

Clinical importance of eflornithine (α-difluoromethylornithine) for the treatment of malignant gliomas
por: Levin, Victor A, et al.
Publicado: (2018)

Difluoromethylornithine rebalances aberrant polyamine ratios in Snyder–Robinson syndrome
por: Stewart, Tracy Murray, et al.
Publicado: (2023)

MDB-03. DFMO AS A TREATMENT STRATEGY IN GROUP 3 MEDULLOBLASTOMA
por: Shahab, Shubin, et al.
Publicado: (2023)

Combined Treatment with a WNT Inhibitor and the NSAID Sulindac Reduces Colon Adenoma Burden in Mice with Truncated APC
por: Faux, Maree C., et al.
Publicado: (2022)

Identifying gene copy number variants associated with colorectal adenoma recurrence
por: Laukaitis, Christina M, et al.
Publicado: (2010)

Chromosomal Instability, Aneuploidy, and Gene Mutations in Human Sporadic Colorectal Adenomas
por: Carvalho, Beatriz
Publicado: (2005)

Chromosomal Instability, Aneuploidy, and Gene Mutations in Human Sporadic Colorectal Adenomas
por: Giaretti, Walter, et al.
Publicado: (2004)

Anti-GD2 induced allodynia in rats can be reduced by pretreatment with DFMO
por: Diccianni, Mitchell B., et al.
Publicado: (2020)

ETMR-18. TARGETING Lin28 IN ETMR WITH ODC1 INHIBITOR DFMO
por: Goodyke, Austin, et al.
Publicado: (2020)

α-Difluoromethylornithine-Induced Cytostasis is Reversed by Exogenous Polyamines, Not by Thymidine Supplementation
por: Hyvönen, Mervi T., et al.
Publicado: (2021)

The efficacy and safety of sulindac for colorectal polyps: A protocol for systematic review and meta-analysis
por: Long, Qing, et al.
Publicado: (2020)

Sulindac for stroke treatment: neuroprotective mechanism and therapy
por: Modi, Jigar Pravinchandra, et al.
Publicado: (2014)

Amine Containing Analogs of Sulindac for Cancer Prevention
por: Mathew, Bini, et al.
Publicado: (2018)

Oxazole and thiazole analogs of sulindac for cancer prevention
por: Mathew, Bini, et al.
Publicado: (2018)

Gender Predilection in Sporadic Parathyroid Adenomas
por: Yavropoulou, Maria P., et al.
Publicado: (2020)

Structural Insight into DFMO Resistant Ornithine Decarboxylase from Entamoeba histolytica: An Inkling to Adaptive Evolution
por: Preeti,, et al.
Publicado: (2013)

Induction and Prevention of Gastric Cancer with Combined Helicobacter Pylori and Capsaicin Administration and DFMO Treatment, Respectively
por: Aziz, Faisal, et al.
Publicado: (2020)

CLRM-14 INTRATUMORAL EXTRACELLULAR METABOLIC IMPACT OF DFMO AND AMXT 1501 IN LIVE HUMAN GLIOMAS
por: Riviere-Cazaux, Cecile, et al.
Publicado: (2022)

Metastasis of hormone-independent breast cancer to lung and bone is decreased by α-difluoromethylornithine treatment
por: Richert, Monica M, et al.
Publicado: (2005)

Identification of the Effects of Aspirin and Sulindac Sulfide on the Inhibition of HMGA2-Mediated Oncogenic Capacities in Colorectal Cancer
por: Ekanem, Titus Ime, et al.
Publicado: (2020)

Cyclin G2, a novel target of sulindac to inhibit cell cycle progression in colorectal cancer
por: Zhao, Hongyou, et al.
Publicado: (2020)

Sulindac Enhances the Killing of Cancer Cells Exposed to Oxidative Stress
por: Marchetti, Maria, et al.
Publicado: (2009)

Sulindac Prevents Esophageal Adenocarcinomas Induced by Gastroduodenal Reflux in Rats
por: Kim, Sung Wook, et al.
Publicado: (2007)

A Desmoid Tumor Responding to Systemic Therapy With Tamoxifen and Sulindac
por: Choudhury, Hasan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gah5prg5utamgodijbr03au1v2